Lab Reagents
Human IgG antibody Laboratories manufactures the avian influenza h9 elisa kit id vet reagents distributed by Genprice. The Avian Influenza H9 Elisa Kit Id Vet reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact influenza elisa. Other Avian products are available in stock. Specificity: Avian Category: Influenza Group: H9 Elisa
H9 Elisa information
Avian Influenza Neuraminidase Antibody |
3421-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Avian Influenza Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the NA protein also contributes to the high virulence of the H5N1 virus. |
Avian Influenza Neuraminidase Antibody |
3421-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Avian Influenza Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the NA protein also contributes to the high virulence of the H5N1 virus. |
Avian Influenza Neuriminidase Peptide |
3421P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) Avian Influenza Neuriminidase peptide |
Avian Influenza Neuraminidase Antibody |
3423-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Avian Influenza Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the NA protein also contributes to the high virulence of the H5N1 virus. |
Avian Influenza Neuraminidase Antibody |
3423-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Avian Influenza Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the NA protein also contributes to the high virulence of the H5N1 virus. |
Avian Influenza Neuriminidase Peptide |
3423P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) Avian Influenza Neuriminidase peptide |
Avian Influenza type ( AM2 ) PCR kit |
PCR-VH599-48R |
Bioingentech |
50T |
EUR 987.6 |
Avian Influenza type ( AM2 ) PCR kit |
PCR-VH599-96R |
Bioingentech |
100T |
EUR 1335.6 |
Avian Influenza A H5N1 PCR kit |
PCR-H441-48R |
Bioingentech |
50T |
EUR 987.6 |
Avian Influenza A H5N1 PCR kit |
PCR-H441-96R |
Bioingentech |
100T |
EUR 1335.6 |
Avian influenza H5N8 RT PCR kit |
RTq-V063-100R |
Bioingentech |
100T |
EUR 1573.2 |
Avian influenza H5N8 RT PCR kit |
RTq-V063-150R |
Bioingentech |
150T |
EUR 2144.4 |
Avian influenza H5N8 RT PCR kit |
RTq-V063-50R |
Bioingentech |
50T |
EUR 1155.6 |
Avian Influenza A Nucleoprotein Antigen Capture ELISA Kit |
DEIA2026 |
Creative Diagnostics |
2 x 96T |
EUR 1554 |
Description: This kit is a highly sensitive and specific enzyme immunoassay for the detection of Influenza A nucleoprotein antigen in complex sample matrices derived from both human and veterinary sources. |
Avian Influenza Virus Antibody (AIV-Ab) ELISA Kit |
abx364805-96tests |
Abbexa |
96 tests |
EUR 764.4 |
|
Avian Influenza A M2 Antibody |
4333-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Avian Influenza A M2 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however, it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. The more recent virulent strain of H5N1 is now seen in Africa and Europe, as well as in Southeast Asia. There is some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. The influenza membrane ion channel (M2) is a small transmembrane protein that regulates the pH inside the virion during viral entry into the cell and protects the newly synthesized hemagglutinin during their transport through low pH cellular compartments. It has been suggested as a target of neutralizing antibodies. |
Avian Influenza A M2 Antibody |
4333-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Avian Influenza A M2 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however, it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. The more recent virulent strain of H5N1 is now seen in Africa and Europe, as well as in Southeast Asia. There is some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. The influenza membrane ion channel (M2) is a small transmembrane protein that regulates the pH inside the virion during viral entry into the cell and protects the newly synthesized hemagglutinin during their transport through low pH cellular compartments. It has been suggested as a target of neutralizing antibodies. |